ZORPEX
Manufacturer Details
SUN PHARMA
Compositions:
Roxatidine acetate hcl 75mg/150mg e.c. tablets,
|
Strength
|
Rate
|
Packing Style
|
|
150mg
|
73.60
|
14s e.c.tablets
|
|
75mg
|
45.00
|
14s e.c tablets
|
List of Related Indications:
- Duodenal & benign gastric ulcr
- Reflux oesophagitis
List Of Drugs:
- Roxatidine @ - Histamine H2 antagonists-(May 1991)
Indication Type Description:
Drug Interaction:
Histamine H2 Antagonists include- Cimetidine, Famotidine, Nizatidine, Ranitidine, Roxatidine Refer - Cimetidine
Indication:
Histamine H2 Antagonists include- Cimetidine, Famotidine, Nizatidine, Ranitidine, Roxatidine Refer - Cimetidine
Duodenal , benign gastric ulcer Reflux oesophagitis
New Drugs Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
Roxatidine acetate Anti-ulcer May 1991
Adverse Reaction:
Hypersensitivity reactions-
transcient impairment of sexual function
Special precautions-
Occaossional headache, Diarrhea, constipation, nausea, vomiting, Sleep disturbances
Contra-Indications:
Malignant gastric ulcers Pregnancy Lactation Children below 14 years of age
Special precautions- Reduce dosage in patients with impaired renal function.
Dosages/ Overdosage Etc:
Approved on- 1991
Indication-
Duodenal , benign gastric ulcer Reflux oesophagitis
Dosage-
150mg in a single or divided dose es Maint- 75mg daiy in the evening
Patient Information:
Histamine H2 Antagonists include- Cimetidine, Famotidine, Nizatidine, Ranitidine, Roxatidine Refer - Cimetidine
Pregnancy and lactation:
Contraindicated in pregnancy and lactation
